These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9712034)

  • 21. Negative selection of T cells occurs throughout thymic development.
    Baldwin KK; Trenchak BP; Altman JD; Davis MM
    J Immunol; 1999 Jul; 163(2):689-98. PubMed ID: 10395659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulatory potential of heteroclitic analogs of the dominant T-cell epitope of lipocalin allergen Bos d 2 on specific T cells.
    Kinnunen T; Kwok WW; Närvänen A; Rytkönen-Nissinen M; Immonen A; Saarelainen S; Taivainen A; Virtanen T
    Int Immunol; 2005 Dec; 17(12):1573-81. PubMed ID: 16221722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mimicry between non-self, modified self and self in autoimmunity.
    Karlsen AE; Dyrberg T
    Semin Immunol; 1998 Feb; 10(1):25-34. PubMed ID: 9529653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parallel cross-reactivity patterns of 2 sets of antigenically distinct cytochrome c peptides: possible evidence for a presentational model of Ir gene function.
    Hansburg D; Hannum C; Inman JK; Appella E; Margoliash E; Schwartz RH
    J Immunol; 1981 Nov; 127(5):1844-51. PubMed ID: 6271869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response.
    Birnboim HC; Lemay AM; Lam DK; Goldstein R; Webb JR
    J Immunol; 2003 Jul; 171(2):528-32. PubMed ID: 12847213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between computed conformational properties of cytochrome c peptides and their antigenicity in a T-lymphocyte proliferation assay.
    Vasquez M; Pincus MR; Scheraga HA
    Biopolymers; 1987 Mar; 26(3):373-86. PubMed ID: 3032295
    [No Abstract]   [Full Text] [Related]  

  • 27. Epitope mimics and determinant spreading: pathways to autoimmunity.
    Farris AD; Keech CL; Gordon TP; McCluskey J
    Cell Mol Life Sci; 2000 Apr; 57(4):569-78. PubMed ID: 11130457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel technique to link either proteins or peptides to gammaglobulin to construct tolerogens.
    Borel H; Borel Y
    J Immunol Methods; 1990 Feb; 126(2):159-68. PubMed ID: 2154521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.
    Buhrman JD; Jordan KR; Munson DJ; Moore BL; Kappler JW; Slansky JE
    J Biol Chem; 2013 Nov; 288(46):33213-25. PubMed ID: 24106273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.
    Sabatino JJ; Rosenthal KM; Evavold BD
    J Neuroimmune Pharmacol; 2010 Jun; 5(2):176-88. PubMed ID: 19904613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.
    Jain N; Reuben JM; Kantarjian H; Li C; Gao H; Lee BN; Cohen EN; Ebarb T; Scheinberg DA; Cortes J
    Cancer; 2009 Sep; 115(17):3924-34. PubMed ID: 19536894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.
    Babatz J; Röllig C; Löbel B; Folprecht G; Haack M; Günther H; Köhne CH; Ehninger G; Schmitz M; Bornhäuser M
    Cancer Immunol Immunother; 2006 Mar; 55(3):268-76. PubMed ID: 16034561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity and recognition efficiency of T cell responses to cancer.
    Stuge TB; Holmes SP; Saharan S; Tuettenberg A; Roederer M; Weber JS; Lee PP
    PLoS Med; 2004 Nov; 1(2):e28. PubMed ID: 15578105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.
    Tangri S; Ishioka GY; Huang X; Sidney J; Southwood S; Fikes J; Sette A
    J Exp Med; 2001 Sep; 194(6):833-46. PubMed ID: 11560998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy.
    Fong L; Hou Y; Rivas A; Benike C; Yuen A; Fisher GA; Davis MM; Engleman EG
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8809-14. PubMed ID: 11427731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative selection during the peripheral immune response to antigen.
    Anderton SM; Radu CG; Lowrey PA; Ward ES; Wraith DC
    J Exp Med; 2001 Jan; 193(1):1-11. PubMed ID: 11136816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common antigenicity between Japanese cedar (Cryptomeria japonica) pollen and Japanese cypress (Chamaecyparis obtusa) pollen, II. Determination of the cross-reacting T-cell epitope of cry j 1 and cha o 1 in mice.
    Ohno N; Ide T; Sakaguchi M; Inouye S; Saito S
    Immunology; 2000 Apr; 99(4):630-4. PubMed ID: 10792512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide.
    Bouhdoud L; Villain P; Merzouki A; Arella M; Couture C
    J Virol; 2000 Mar; 74(5):2121-30. PubMed ID: 10666241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope.
    Wang R; Wang-Zhu Y; Gabaglia CR; Kimachi K; Grey HM
    J Exp Med; 1999 Oct; 190(7):983-94. PubMed ID: 10510088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues.
    Zügel U; Wang R; Shih G; Sette A; Alexander J; Grey HM
    J Immunol; 1998 Aug; 161(4):1705-9. PubMed ID: 9712034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.